Physician profile

William H Foresman

Urology · Auburn, NY

NPI 1790758639

$1,427.54

in general payments reported to CMS, 2019-2025

24 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Biotech, INC. $266.70 2019-2020
Astellas Pharma US INC $258.36 2019-2020
Neotract INC. $145.26 2019
Dendreon Pharmaceuticals LLC $111.44 2019-2020
Tolmar Pharmaceuticals, INC. $87.31 2019
Bayer Healthcare Pharmaceuticals INC. $79.16 2019-2020
Medtronic USA, INC. $56.74 2019
Blue Earth Diagnostics $50.73 2019
Pfizer INC. $50.19 2019
Therapeuticsmd, INC. $48.00 2019
Abbvie INC. $34.13 2019
Coloplast Corp $32.21 2019-2020
180 Medical, INC. $31.69 2019-2020
Endo Pharmaceuticals INC. $31.52 2019
Rochester Medical Corporation $19.37 2019
Show all 24 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $16.20 2019
Boston Scientific Corporation $15.83 2019
Dentsply Ih INC. $15.68 2020
Antares Pharma, INC. $15.14 2020
Sun Pharmaceutical Industries INC. $15.07 2019
Cook Medical LLC $13.77 2020
Allergan, INC. $12.52 2019
Metuchen Pharmaceuticals $11.98 2019
Janssen Pharmaceuticals, INC $8.54 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

William H Foresman

$1,427.54

in general payments reported 2019-2025

Years
2019-2020
Top company
Janssen Biotech, INC.

https://glasscript.com/doctor/307608/william-h-foresman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.